<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Gen Intern Med</journal-id><journal-id journal-id-type="iso-abbrev">J Gen Intern Med</journal-id><journal-id journal-id-type="pmc-domain-id">227</journal-id><journal-id journal-id-type="pmc-domain">jgimed</journal-id><journal-title-group><journal-title>Journal of General Internal Medicine</journal-title></journal-title-group><issn pub-type="ppub">0884-8734</issn><issn pub-type="epub">1525-1497</issn><publisher><publisher-name>Springer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10039204</article-id><article-id pub-id-type="pmcid-ver">PMC10039204.1</article-id><article-id pub-id-type="pmcaid">10039204</article-id><article-id pub-id-type="pmcaiid">10039204</article-id><article-id pub-id-type="pmid">36229762</article-id><article-id pub-id-type="doi">10.1007/s11606-022-07793-x</article-id><article-id pub-id-type="publisher-id">7793</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Research</subject></subj-group></article-categories><title-group><article-title>National Estimates and Physician-Reported Impacts of Prescription Drug Monitoring Program Use</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-9558-3437</contrib-id><name name-style="western"><surname>Richwine</surname><given-names initials="C">Chelsea</given-names></name><degrees>PhD</degrees><address><email>Chelsea.Richwine@hhs.gov</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Everson</surname><given-names initials="J">Jordan</given-names></name><degrees>PhD</degrees><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="GRID">grid.483417.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 0616 3804</institution-id><institution>Office of Technology, </institution><institution>Office of the National Coordinator for Health Information Technology, </institution></institution-wrap>Washington, DC USA </aff></contrib-group><pub-date pub-type="epub"><day>13</day><month>10</month><year>2022</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2023</year></pub-date><volume>38</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">432031</issue-id><fpage>881</fpage><lpage>888</lpage><history><date date-type="received"><day>3</day><month>3</month><year>2022</year></date><date date-type="accepted"><day>6</day><month>9</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>01</day><month>03</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>01</day><month>03</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-03-01 00:25:10.097"><day>01</day><month>03</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply 2022</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="11606_2022_Article_7793.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">Despite widespread adoption of state prescription drug monitoring programs (PDMPs), it is unclear how often PDMPs are accessed through an electronic health record system (EHR-PDMP integration), or whether efforts to make PDMPs easier to access and use have improved their utility.</p></sec><sec><title>Objective</title><p id="Par2">To produce national-level estimates on the use of PDMPs among office-based physicians and benefits associated with their use.</p></sec><sec><title>Design</title><p id="Par3">We use nationally representative survey data to produce descriptive statistics on PDMP use and associated benefits among office-based physicians in the USA.</p></sec><sec><title>Participants</title><p id="Par4">1398 office-based physicians who prescribe controlled substances.</p></sec><sec><title>Main Measures</title><p id="Par5">We examined physician-reported ease and frequency of PDMP use, and how EHR-PDMP integration affects frequency and ease of use. Multivariate models were used to assess whether characteristics of PDMP use were related to physician-reported benefits such as reduced prescribing of controlled substances and perceived improvements in clinical decision-making.</p></sec><sec><title>Key Results</title><p id="Par6">In 2019, two-thirds of office-based physicians in the USA reported frequent use of their state PDMP and over three-quarters reported they were easy to use. Both frequency and ease of use were positively correlated with PDMP integration status. Respondents who frequently checked their state&#8217;s PDMP were 8.7 percentage points (95% CI &#8722;.4 to 17.8) more likely to report perceived benefits and reported 2.2 (95% CI 1.54 to 2.83) more benefits. Respondents who indicated their PDMP was easy to use were 12.7 percentage points (95% CI .040 to .214) more likely to report perceived benefits and reported 0.94 (95% CI 0.26 to 1.61) more benefits.</p></sec><sec><title>Conclusions</title><p id="Par7">Our findings suggest efforts to make PDMPs easier to access and use aided physicians in making informed clinical decisions that may not be captured by reduced prescribing alone. Efforts to further increase frequency and ease of use&#8212;including advancing a standards-based approach to PDMP and EHR data interoperability&#8212;may further increase the benefit of PDMPs.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1007/s11606-022-07793-x.</p></sec></abstract><kwd-group xml:lang="en"><title>KEY WORDS</title><kwd>prescription drug monitoring programs</kwd><kwd>physicians</kwd><kwd>opioid prescribing</kwd><kwd>electronic health records</kwd><kwd>quality</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; The Author(s), under exclusive licence to Society of General Internal Medicine 2023</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>